JRSS (JRSIS Health Care) EBITDA Margin %: 18.12% (As of Mar. 2025)

What is JRSIS Health Care EBITDA Margin %?

JRSIS Health Care JRSS EBITDA Margin % is 18.12% as of Mar. 2025.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. JRSIS Health Care's EBITDA for the three months ended in Mar. 2025 was $0.03 Mil. JRSIS Health Care's Revenue for the three months ended in Mar. 2025 was $0.14 Mil. Therefore, JRSIS Health Care's EBITDA margin for the quarter that ended in Mar. 2025 was 18.12%.

JRSIS Health Care (OTCPK:JRSS) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

JRSIS Health Care EBITDA Margin % Related Terms

JRSIS Health Care EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for JRSIS Health Care's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JRSIS Health Care EBITDA Margin % Chart

JRSIS Health Care Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBITDA Margin %

Get a 7-Day Free Trial

25.29

0.00

-32.81

-3.76

-33.96

JRSIS Health Care Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EBITDA Margin %	Get a 7-Day Free Trial															-29.60	-14.74	-86.55	-525.00	18.12

JRSS vs NVVE, FTEL, QSJC: EBITDA Margin % Comparison

For the Specialty Retail subindustry, JRSIS Health Care's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JRSIS Health Care EBITDA Margin % vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, JRSIS Health Care's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where JRSIS Health Care's EBITDA Margin % falls into.

Save Embed

JRSIS Health Care EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

JRSIS Health Care's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-0.45	/	1.325
	=	-33.96 %

JRSIS Health Care's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %	=	EBITDA (Q: Mar. 2025 )	/	Revenue (Q: Mar. 2025 )
	=	0.025	/	0.138
	=	18.12 %

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of 18.12% mean?

JRSIS Health Care (JRSS) has a EBITDA Margin % of 18.12% as of Mar. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on JRSIS Health Care and its competitors.

Is JRSIS Health Care's EBITDA Margin % too high?

JRSIS Health Care's current EBITDA Margin % is 18.12%. The Retail - Cyclical industry median EBITDA Margin % is 7.48. JRSIS Health Care's value of 18.12% is 142.2% above this industry median.

How does JRSIS Health Care's EBITDA Margin % compare to NVVE and FTEL?

JRSIS Health Care's EBITDA Margin % of 18.12% can be compared against companies in the Retail - Cyclical industry. The industry median EBITDA Margin % is 7.48. JRSIS Health Care's value of 18.12% is 142.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Retail - Cyclical company?

The median EBITDA Margin % among Retail - Cyclical companies is 7.48, based on 1,128 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JRSIS Health Care's current EBITDA Margin % of 18.12% is 142.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on JRSIS Health Care and its competitors. For the Retail - Cyclical industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JRSIS Health Care's current EBITDA Margin % is 18.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is JRSIS Health Care stock overvalued right now?

JRSIS Health Care (JRSS) has a current EBITDA Margin % of 18.12%. The current EBITDA Margin % is 18.12% and 142.2% above the Retail - Cyclical industry median of 7.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For JRSIS Health Care (JRSS), the current EBITDA Margin % is 18.12% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

JRSIS Health Care Business Description

Industry Consumer Cyclical Retail - Cyclical

Comparable Companies NVVE FTEL QSJC LNBY SPEV GHST BQ TSX:ATD ULTA SHSE:601888 TSCO WSM CASY DKS ADX:ADNOCDIST BBY FIVE GME TPE:3045 XSWX:AVOL

Address Yongzhou Economic and Technology Development Zone, Building 2, Youth Innovation and Entrepreneurship Park, Xiaoxiang Science and Technology Innovation Center, Hunan Province, Yongzhou, CHN, 425000

Website http://www.jhcc.cn

JRSIS Health Care Corp, through its subsidiaries, is mainly engaged in providing charging services to electric vehicles incorporated in Zhongshan City of Guangdong, China.